cardiovascular outcomes
Advertisement
Hyperuricemia and gout are predictors of increased prevalence and mortality of cardiac, renal, and metabolic conditions.
Meta-analyses reaffirmed cardiovascular and renal benefits of long-acting GLP-1RAs for patients with type 2 diabetes.
Variability in eGFR over time is associated with risks of cardiovascular and kidney outcomes and mortality in those with CKD.
Iron therapy may reduce cardiovascular risks for patients with chronic kidney disease, a study found.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.